Histologic transformation is regarded as the resistance mechanism against EGFR [28], ALK [29], or immunotherapy [18], and the frequency of transformation to SCLC is reported to be in the range of 3–14% [30,31]. Here, ALK is linked to small cell lung carcinoma.